Panel Discussion: Harnessing Multimodal Technologies to Improve Patient Profiling for Increased Accuracy in Diagnostics

• Integrating protein, methylation and fragmentomic signal to resolve cases that genomic profiling alone leaves ambiguous
• Determining which analyte combinations improve accuracy enough to justify the added cost and complexity
• Embedding multi-omic workflows into patient selection and diagnostic paradigms

Speakers:

Shibu Thomas

Senior Scientific Director, Biomarkers

Johnson & Johnson

Dimple Modi

Senior Director. Oncology Precision Medicine

Regeneron Pharmaceuticals

Ildiko Csiki

Vice President, Head of External Innovation & Oncology

Pfizer

Ryan Hartmaier

Executive Director, Multimodal & Minimally Invasive Biomarkers, Oncology Research & Development

AstraZeneca